| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.27 | 0.08 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.075 | 0.08 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.09 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |